All data are based on the daily closing price as of January 9, 2026
g

Grape King Bio

1707.TW
3.93 USD
-0.02
-0.51%

Overview

Last close
3.93 usd
Market cap
581.46M usd
52 week high
4.87 usd
52 week low
3.91 usd
Target price
5.41 usd

Valuation

P/E
15.1404
Forward P/E
17.3611
Price/Sales
1.7655
Price/Book Value
1.8166
Enterprise Value
487.90M usd
EV/Revenue
1.4814
EV/EBITDA
5.3692

Key financials

Revenue TTM
329.35M usd
Gross Profit TTM
249.18M usd
EBITDA TTM
85.35M usd
Earnings per Share
0.26 usd
Dividend
0.2 usd
Total assets
475.39M usd
Net debt
-95.83M usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functional ingredients for intestinal care, weight control, liver care, brain health, eye care, feminine health, and sensual health care; and microbial fermentation, as well as food inspection services. In addition, the company offers health foods, beverages, cosmetics, and general and pet food. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top